COPD–do the right thing

H Sandelowsky, UM Weinreich, BB Aarli, J Sundh… - BMC family …, 2021 - Springer
A gap exists between guidelines and real-world clinical practice for the management and
treatment of chronic obstructive pulmonary disease (COPD). Although this has narrowed in …

[HTML][HTML] Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life

JR Hurst, N Skolnik, GJ Hansen, A Anzueto… - European journal of …, 2020 - Elsevier
Exacerbations of chronic obstructive pulmonary disease (COPD) represent a significant
clinical problem, and are associated with decreased lung function, worsening quality of life …

Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal

V Bellou, L Belbasis, AK Konstantinidis, I Tzoulaki… - Bmj, 2019 - bmj.com
Objective To map and assess prognostic models for outcome prediction in patients with
chronic obstructive pulmonary disease (COPD). Design Systematic review. Data sources …

FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease

A Bikov, P Lange, JA Anderson, RD Brook… - … journal of chronic …, 2020 - Taylor & Francis
Purpose Chronic obstructive pulmonary disease (COPD) is one of the leading causes of
death worldwide. Impaired lung function is associated with heightened risk for death …

DElaying disease progression in COPD with early initiation of dual bronchodilator or triple inhaled pharmacotherapy (DEPICT): a predictive modelling approach

D Singh, D Litewka, R Páramo, A Rendon… - Advances in …, 2023 - Springer
Introduction Clinical studies demonstrate an accelerated decline in lung function in patients
with moderate chronic obstructive pulmonary disease (COPD)(Global Initiative for Chronic …

COPD Exacerbation history and impact on future exacerbations–8-year retrospective observational database cohort study from Germany

CF Vogelmeier, J Diesing, N Kossack… - … Journal of Chronic …, 2021 - Taylor & Francis
Background Recent studies evaluating the predictive value of different variables on future
exacerbations suggest exacerbation history as the strongest predictor. We examined the …

Validation of COPDPredict™: unique combination of remote monitoring and exacerbation prediction to support preventative management of COPD exacerbations

N Patel, K Kinmond, P Jones, P Birks… - International journal of …, 2021 - Taylor & Francis
Background COPDPredict™ is a novel digital application dedicated to providing early
warning of imminent COPD (chronic obstructive pulmonary disease) exacerbations for …

Serum IgG levels and risk of COPD hospitalization: a pooled meta-analysis

FS Leitao Filho, A Mattman, R Schellenberg, GJ Criner… - Chest, 2020 - Elsevier
Background Hypogammaglobulinemia (serum IgG levels< 7.0 g/L) has been associated with
increased risk of COPD exacerbations but has not yet been shown to predict …

Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective

D Singh, AD D'Urzo, JF Donohue, EM Kerwin - Respiratory research, 2019 - Springer
There is increasing focus on understanding the nature of chronic obstructive pulmonary
disease (COPD) during the earlier stages. Mild COPD (Global Initiative for Chronic …

[HTML][HTML] Manejo de la EPOC en la era moderna

J Dreyse - Revista Médica Clínica Las Condes, 2024 - Elsevier
La enfermedad pulmonar obstructiva crónica (EPOC) es una patología heterogénea que
impacta a más de 380 millones de personas globalmente, siendo la tercera causa de …